APLN and obesity due to melanocortin 4 receptor deficiency: Apelin is a recently discovered adipokine that has been reported to improve sugar intake and insulin sensitivity, to promote energy consumption, and to reduce blood pressure, while also being important in obesity-related metabolic disease [17, 43].